Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
price target lowered at Citi by a dollar to $27 as product issues materialize, Citigroup said. Maintain Hold rating.
estimates, target cut at Goldman. Shares of ARO now seen reaching $25. Estimates also lowered, given lower realized margins. Neutral rating.
numbers raised at Goldman. Shares of CF now seen reaching $155, according to Goldman Sachs. Estimates also increased, because of lower natural gas prices. Buy rating.
target, estimates lifted at Barclays. CME price target increased to $312 from $307. Strong quarter-to-date volumes, Barclays said. 2010 and 2011 EPS estimates raised to $15.62 and $17.55, respectively. Maintain Equal Weight rating.
estimates, target boosted at Piper. Shares of DECK now seen reaching $75, according to Piper Jaffray. Estimates were also upped, given continued sales momentum for the UGG brand. Neutral rating.
estimates upped at Jefferies. EXC estimates were boosted through 2013, Jefferies said. Company is seeing a better pricing environment. Hold rating and $42.50 price target.
estimates lowered at Goldman through 2012. Company is facing higher costs and seeing lower sales. Buy rating and $17 price target.
numbers boosted at UBS. Shares of FL now seen reaching $20. Estimates also upped, as the company is realizing higher sales. Neutral rating.
price target increased at Citi. FNSR price target raised to $22 from $19 as 2Q11 results reflect solid execution and support bullish optical cycle view. Maintain Hold rating.
estimates, target raised at Citigroup. Shares of FNSR now seen reaching $22, according to Citigroup. Estimates also increased, given better optical demand. Hold rating.
price target boosted at Credit Suisse to $30 from $25. Growing faster than end markets, but that might be sustainable due to market share gains and beneficial mix, Credit Suisse said. Maintain Outperform rating.
numbers lowered at Goldman. Shares of GXP now seen reaching $20, according to Goldman Sachs. Estimates also cut, given the new rates in Kansas. Neutral rating.
numbers boosted at Barclays. ICE price target raised to $125 from $123. Strong volumes in all commodity and FX classes, Barclays said. 2010 and 2011 EPS estimate improved to $5.67 and $6.59, respectively. Maintain Overweight rating.
target boosted at Goldman. Shares of LOW now seen reaching $27. Company should benefit from a higher market multiple. Buy rating.
numbers increased at Goldman. LYB estimates were raised through 2012, Goldman Sachs said. Company should benefit from lower ethane costs. Buy rating and new $39 price target.
( MOT) estimate lower at Barclays. MOT 2011 EPS estimate cut to $0.44 from $0.48, 2010 maintained at $0.34. We maintain positive view despite a downtick in 1Q phone margins, Barclays said. Maintain Overweight rating and $10 price target.
estimates increased at Goldman through 2013. Recent acquisitions should add to earnings. Neutral rating and $17.50 price target.
target, estimates increased at Barclays. NYX price target raised a dollar to $31. Cash equity volumes have been running at steady levels through the first two months of 4Q10, Barclays said. 2010 and 2011 EPS estimate lifted to $2.06 and $2.69, respectively. Maintain Overweight rating.
estimates, target increased at UBS. OMC estimates were raised through 2011. Channel checks suggest that the company is positioned well for the new year. Neutral rating and new $45 price target.
estimates, target raised at UBS. Shares of ORCL now seen reaching $33, according to UBS. Estimates also upped, given higher expected enterprise spending. Buy rating.
added to Conviction Buy List at Goldman Sachs. 401(k) market is improving and the company may begin repurchasing stock in 2011.
estimates cut at UBS through 2011. Company has a mixed sales outlook for the new year. Buy rating and $31 price target.
estimates increased at Morgan Stanley through 2011. Company is seeing better sales and keeping a tight lid on costs. Equal-weight rating.
numbers raised at Keybanc. Shares of ROP now seen reaching $82. Estimates also increased, as the company has strong operating momentum heading into the new year. Buy rating.
numbers reduced at Goldman through 2012. Company is not positioned well for the holiday season. Buy rating and new $22 price target.
estimates cut at Credit Suisse. SCMR 2011 and 2012 EPS estimate lowered to -$0.64 and -$0.31, respectively. Weak revenue and EPS in 1Q11 results, Credit Suisse said. Maintain Outperform rating and $33 price target.
estimates, target raised at Oppenheimer. Shares of SMTC now seen reaching $28. Estimates also increased, to match the company's new guidance. Outperform rating.
numbers upped at Goldman. TSCO estimates were boosted through 2012. Company is realizing higher sales. Sell rating and new $41 price target.
price target raised at Citi. TXN price target jumped to $35 from $31 reflecting a higher multiple, Citigroup said. Maintain Buy rating.
This article was written by a staff member of TheStreet.